20 June 2013
Keywords: probiogen, signs, research, deal, merck, co, germany
Article | 12 December 2001
Germany's ProBioGen AG says it has entered into an exclusive researchand license agreement with Merck & Co to explore the development ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 December 2001
13 December 2001
19 June 2013
© 2013 thepharmaletter.com